Lamdong Pharmaceutical

LDP

VN000000LDP3

Pharmaceuticals

End-of-day quote HANOI S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
23,000 ^VND	0.00%		-0.86%	+44.65%

Apr. 17	Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 10	Lamdong Pharmaceutical Joint Stock Company announced that it expects to receive VND 907.5 billion in funding	CI

Louis Capital Joint Stock Company acquired 10.23% stake in Lamdong Pharmaceutical Joint Stock Company.

December 09, 2021

Louis Capital Joint Stock Company (HOSE:TGG) agreed to acquire a 10.23% stake in Lamdong Pharmaceutical Joint Stock Company (HNX:LDP) on December 8, 2021. Louis Capital will acquire 1.3 million shares in Lamdong Pharmaceutical Joint Stock Company. Transaction has been approved by the Board of Directors of Louis Capital.

Louis Capital Joint Stock Company (HOSE:TGG) completed the acquisition of 10.23% stake in Lamdong Pharmaceutical Joint Stock Company (HNX:LDP) on December 8, 2021.

Latest news about Lamdong Pharmaceutical

Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17	CI
Lamdong Pharmaceutical Joint Stock Company announced that it expects to receive VND 907.5 billion in funding	Apr. 09	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 29	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 29	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-24	CI
APG Securities Joint Stock Company acquired additional 3.71% stake in Lamdong Pharmaceutical Joint Stock Company.	23-04-18	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-19	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-19	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-22	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-22	CI
Ladophar Herbal Beverage One Member Company Limited announced that it expects to receive VND 74 billion in funding from Lamdong Pharmaceutical Joint Stock Company	22-04-11	CI
Ladophar Pharmaceutical Research & Application Co., Ltd announced that it expects to receive VND 40 billion in funding from Lamdong Pharmaceutical Joint Stock Company	22-04-11	CI
Louis Land Joint Stock Company acquired 10.39% shares of Lamdong Pharmaceutical Joint Stock Company.	21-12-16	CI
Louis Capital Joint Stock Company acquired 10.23% stake in Lamdong Pharmaceutical Joint Stock Company.	21-12-09	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-21	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-21	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-20	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-21	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-20	CI
Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20-01-19	CI
Lam Dong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-10-21	CI

Chart Lamdong Pharmaceutical

Duration

Period

More charts

Company Profile

Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LAMDONG PHARMACEUTICAL	+44.65%	11.48M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Lamdong Pharmaceutical

Equities

LDP

VN000000LDP3

Pharmaceuticals

Louis Capital Joint Stock Company acquired 10.23% stake in Lamdong Pharmaceutical Joint Stock Company.

Latest news about Lamdong Pharmaceutical

Chart Lamdong Pharmaceutical

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals